MARKET

ICLR

ICLR

ICON PLC
NASDAQ
209.49
-5.01
-2.34%
After Hours: 211.93 +2.44 +1.16% 19:59 12/05 EST
OPEN
213.90
PREV CLOSE
214.50
HIGH
215.54
LOW
209.25
VOLUME
878.82K
TURNOVER
--
52 WEEK HIGH
347.72
52 WEEK LOW
183.38
MARKET CAP
17.30B
P/E (TTM)
23.29
1D
5D
1M
3M
1Y
5Y
1D
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
Barchart · 19h ago
Weekly Report: what happened at ICLR last week (1125-1129)?
Weekly Report · 3d ago
ICON: Disappointing Change In Trajectory (Rating Downgrade)
Seeking Alpha · 6d ago
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Barchart · 11/27 15:00
Trump taps Jay Bhattacharya to lead National Institutes of Health
Seeking Alpha · 11/27 11:23
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Barchart · 11/26 11:00
The Law Offices of Frank R. Cruz Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors
Barchart · 11/25 11:00
Weekly Report: what happened at ICLR last week (1118-1122)?
Weekly Report · 11/25 09:18
More
About ICLR
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Webull offers ICON PLC stock information, including NASDAQ: ICLR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICLR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICLR stock methods without spending real money on the virtual paper trading platform.